Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
about
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interfaceWEDGE: an anticoagulant thrombin mutant produced by autoactivation.Utility of microfluidic devices to study the platelet-endothelium interface.Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice.Thrombomodulin-dependent protein C activation is required for mitochondrial function and myelination in the central nervous system.
P2860
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@ast
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@en
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@nl
type
label
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@ast
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@en
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@nl
prefLabel
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@ast
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@en
Thrombin mutant W215A/E217A tr ...... autoimmune encephalomyelitis.
@nl
P2093
P2860
P1476
Thrombin mutant W215A/E217A tr ...... l autoimmune encephalomyelitis
@en
P2093
Erik I Tucker
Halina Offner
Kevin G Phillips
Laura D Healy
Norah G Verbout
Owen J T McCarty
Xiaolin Yu
P2860
P2888
P356
10.1007/S11011-014-9558-8
P577
2014-05-09T00:00:00Z
P5875
P6179
1001679085